Filtered By:
Condition: Patent Foramen Ovale

This page shows you your search results in order of relevance. This is page number 8.

Order by Relevance | Date

Total 1415 results found since Jan 2013.

Patent foramen ovale (PFO), stroke and pregnancy
Patent foramen ovale (PFO)-related stroke is increasingly recognized as an important etiology of ischemic embolic stroke—accounting for up to 50% of strokes previously considered ‘cryptogenic’ or with an unknown mechanism. As a ‘back door to the brain,’ PFO can allow venous clots to enter arterial circulation via interatrial right-to-left shunting, potentially resulting in ischemic stroke. We observe that clinically, PFO-related stroke affects women of childbearing age, and that pregnancy—owing to major changes in hemocoagulative, hormonal, and cardiovascular parameters—can enhance...
Source: Journal of Investigative Medicine - May 23, 2016 Category: Research Authors: Chen, L., Deng, W., Palacios, I., Inglessis-Azuaje, I., McMullin, D., Zhou, D., Lo, E. H., Buonanno, F., Ning, M. Tags: Review Source Type: research

Device Closure Versus Medical Therapy Alone for Patent Foramen Ovale in Patients With Cryptogenic Stroke: A Systematic Review and Meta-analysis.
Conclusion: In patients with PFO and cryptogenic stroke, transcatheter device closure decreases risk for recurrent stroke compared with medical therapy alone. Because recurrent stroke rates are low even with medical therapy alone and PFO closure might affect AF risk, shared decision making is crucial for this treatment. Primary Funding Source: None. PMID: 29310136 [PubMed - as supplied by publisher]
Source: Annals of Internal Medicine - January 9, 2018 Category: Internal Medicine Authors: Shah R, Nayyar M, Jovin IS, Rashid A, Bondy BR, Fan TM, Flaherty MP, Rao SV Tags: Ann Intern Med Source Type: research

Interaction of cardiac implantable electronic device and patent foramen ovale in ischemic stroke: A case ‐only study
ConclusionAmong admitted ischemic stroke patients, we did not find a higher prevalence of CIED in patients with PFO compared to controls. Therefore, in the underlying source population, the presence of CIED did not increase the PFO ‐associated ischemic stroke risk.This article is protected by copyright. All rights reserved
Source: Pacing and Clinical Electrophysiology : PACE - January 8, 2019 Category: Cardiology Authors: Kolade M. Agboola, Jin ‐Moo Lee, Xiaoyan Liu, Eric Novak, Phillip S. Cuculich, Daniel H. Cooper, Amit Noheria Tags: DEVICES Source Type: research

ADAMTS-13 activity in stroke of known and unknown cause: Relation to vascular risk factor burden
ConclusionADAMTS-13 activity is inversely correlated with the number of vascular risk factors across different stroke etiologies. Further study is warranted to establish ADAMTS-13 as a mediator of cerebrovascular risk.
Source: Frontiers in Neurology - January 10, 2023 Category: Neurology Source Type: research

Patent Foramen Ovale, Subclinical Cerebrovascular Disease, and Ischemic Stroke in a Population-Based Cohort
ConclusionsIn this community-based cohort, PFO was not associated with an increased risk of clinical stroke or subclinical cerebrovascular disease.
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - June 24, 2013 Category: Cardiology Source Type: research

Utility of Pelvic MRV in Evaluation of Patients with Cryptogenic Stroke and PFO (P4.228)
CONCLUSIONS: Our data expands on prior study showing that pelvic MRV has the potential to identify a stroke source in patients with cryptogenic stroke, absent identifiable hypercoagulability state, and PFO.Disclosure: Dr. Osgood has nothing to disclose. Dr. Budman has nothing to disclose. Dr. Henninger has received personal compensation for activities with Brainsgate as a consultant.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Osgood, M., Budman, E., Henninger, N. Tags: Cerebrovascular Disease and Interventional Neurology: Cardiac Source Type: research

Effect of Patent Foramen Ovale (PFO) Endovascular Closure on Stroke Quality of Life (P4.229)
Conclusion: PFO stroke patients have improved quality of life after PFO closure as measured by validated quantitative anxiety and depression scales under multi-disciplinary care. Patient’s stress hormone levels were also lowered post PFO closure. These findings demonstrate the importance of a multi-disciplinary approach to stroke patient care, and individualizing care in younger stroke patients. Longer term future studies are needed to understand the effect of PFO closure vs multi-disciplinary specialized care.Study Supported by: NIH/NINDSDisclosure: Dr. K has nothing to disclose. Dr. Ning has nothing to disclose. Dr...
Source: Neurology - April 9, 2014 Category: Neurology Authors: K, F.-H., Ning, M., Deng, W., Wickham, T., Inglessis, I., Lo, E., Palacios, I., Buonanno, F. Tags: Cerebrovascular Disease and Interventional Neurology: Cardiac Source Type: research

Implanted endocardial lead characteristics and risk of stroke or transient ischemic attack
Conclusions Most physical characteristics of contemporary leads do not impact rate of stroke/TIA among patients receiving implantable devices. The presence of a PFO is a major risk factor for stroke/TIA in patients with endovascular leads.
Source: Journal of Interventional Cardiac Electrophysiology - September 25, 2014 Category: Cardiology Source Type: research

Prevalence of Patent Foramen Ovale in Ischaemic Stroke in Italy: Results of SISIFO Study
Conclusion: If any relationship exists between stroke and PFO, this is more likely in PACI and POCI at a younger age. Our results are consistent with recent findings that underline PFO alone must not be considered a significant independent predictor for stroke; so the presence of PFO alone doesn't permit rushed causal correlations or ‘therapeutic aggressiveness'.Cerebrovasc Dis 2015;39:162-169
Source: Cerebrovascular Diseases - February 26, 2015 Category: Neurology Source Type: research

"I Had A Stroke at 38 Years Old"
How one woman turned a life-changing event into an opportunity to thrive. As told to Kristin Canning By Kristin Canning, SELF (Photo: Courtesy of Merideth Gilmor) I wasn't supposed to have a stroke. I was 38 years old, a mom in "perfect" health. I run my own pro-athlete public relations firm, so I have to stay on pace with the likes of Maria Sharapova, Cam Newton and Colin Kaepernick. I was under stress, sure, but I was happy, enjoying my crazy, packed days. It happened about a year ago. One of my best friends was getting married in the Berkshire Mountains, so I flew from Charlotte, North Carolina, where I'd been on busin...
Source: Healthy Living - The Huffington Post - August 26, 2015 Category: Consumer Health News Source Type: news

Can neuroimaging differentiate PFO and AF-related cardioembolic stroke from the other embolic sources? Clinical-radiological correlation on a retrospective study
ConclusionIn clinical practice, PFO may be considered a cause of cortical stroke on the basis of radiological findings, when VB vascular territory or MS brain involvement is present in younger patients (<50 age).
Source: La Radiologia Medica - February 20, 2017 Category: Radiology Source Type: research

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
Publication date: Available online 28 September 2018Source: The Lancet NeurologyAuthor(s): Scott E Kasner, Balakumar Swaminathan, Pablo Lavados, Mukul Sharma, Keith Muir, Roland Veltkamp, Sebastian F Ameriso, Matthias Endres, Helmi Lutsep, Steven R Messé, J David Spence, Krassen Nedeltechev, Kanjana Perera, Gustavo Santo, Veronica Olavarria, Arne Lindgren, Shrikant Bangdiwala, Ashkan Shoamanesh, Scott D Berkowitz, Hardi MundlSummaryBackgroundPatent foramen ovale (PFO) is a contributor to embolic stroke of undetermined source (ESUS). Subgroup analyses from previous studies suggest that anticoagulation could reduce recurren...
Source: The Lancet Neurology - October 5, 2018 Category: Neurology Source Type: research

Aura and Stroke: relationship and what we have learnt from preclinical models
ConclusionPreclinical models suggest a key role for enhanced SD susceptibility and microembolization to explain both the occurrence of migraine attacks and the increased stroke risk in migraineurs. Therapeutic targeting of SD and microembolic events, or potential causes thereof, will be promising for treatment of aura and may also prevent ischemic infarction in vulnerable brains.
Source: The Journal of Headache and Pain - May 28, 2019 Category: Neurology Source Type: research